Cho HJ - Search Results

1

Regulation of Rho GTPases by RhoGDIs in Human Cancers.

Cho HJ, Kim JT, Baek KE, Kim BY, Lee HG. Cho HJ, et al. Cells. 2019 Sep 5;8(9):1037. doi: 10.3390/cells8091037. Cells. 2019. PMID: 31492019 Free PMC article. Review.

2

Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.

Kim JK, Kim KD, Lee E, Lim JS, Cho HJ, Yoon HK, Cho MY, Baek KE, Park YP, Paik SG, Choe YK, Lee HG. Kim JK, et al. Among authors: cho hj, cho my. Cancer Lett. 2004 Aug 20;212(1):61-70. doi: 10.1016/j.canlet.2004.02.021. Cancer Lett. 2004. PMID: 15246562

3

Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.

Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM, Song EY, Lim JS, Yoon DY, Lee HG, Choe YK. Cho HJ, et al. Among authors: cho my. Cancer Lett. 2006 Jun 8;237(1):56-66. doi: 10.1016/j.canlet.2005.05.039. Epub 2005 Jul 11. Cancer Lett. 2006. PMID: 16009487

4

Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway.

Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J. Cho HJ, et al. Biochem Biophys Res Commun. 2007 Feb 9;353(2):337-43. doi: 10.1016/j.bbrc.2006.12.035. Epub 2006 Dec 14. Biochem Biophys Res Commun. 2007. PMID: 17187756

5

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.

Cho HJ, Baek KE, Park SM, Kim IK, Choi YL, Cho HJ, Nam IK, Hwang EM, Park JY, Han JY, Kang SS, Kim DC, Lee WS, Lee MN, Oh GT, Kim JW, Lee CW, Yoo J. Cho HJ, et al. Clin Cancer Res. 2009 Apr 15;15(8):2612-9. doi: 10.1158/1078-0432.CCR-08-2192. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351766

6

RhoGDI2 as a therapeutic target in cancer.

Cho HJ, Baek KE, Yoo J. Cho HJ, et al. Expert Opin Ther Targets. 2010 Jan;14(1):67-75. doi: 10.1517/14728220903449251. Expert Opin Ther Targets. 2010. PMID: 20001211 Review.

7

Gadd45b mediates Fas-induced apoptosis by enhancing the interaction between p38 and retinoblastoma tumor suppressor.

Cho HJ, Park SM, Hwang EM, Baek KE, Kim IK, Nam IK, Im MJ, Park SH, Bae S, Park JY, Yoo J. Cho HJ, et al. J Biol Chem. 2010 Aug 13;285(33):25500-5. doi: 10.1074/jbc.M109.091413. Epub 2010 Jun 17. J Biol Chem. 2010. PMID: 20558744 Free PMC article.

8

RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.

Cho HJ, Baek KE, Park SM, Kim IK, Nam IK, Choi YL, Park SH, Im MJ, Choi J, Ryu J, Kim JW, Lee CW, Kang SS, Yoo J. Cho HJ, et al. Cancer Lett. 2011 Dec 1;311(1):48-56. doi: 10.1016/j.canlet.2011.06.024. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21752536

9

PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.

Cho HJ, Baek KE, Nam IK, Park SM, Kim IK, Park SH, Im MJ, Ryu KJ, Yoo JM, Hong SC, Kim JW, Lee CW, Yoo J. Cho HJ, et al. Biochem Biophys Res Commun. 2011 Oct 28;414(3):575-80. doi: 10.1016/j.bbrc.2011.09.121. Epub 2011 Oct 1. Biochem Biophys Res Commun. 2011. PMID: 21986528

10

Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.

Cho HJ, Baek KE, Kim IK, Park SM, Choi YL, Nam IK, Park SH, Im MJ, Yoo JM, Ryu KJ, Oh YT, Hong SC, Kwon OH, Kim JW, Lee CW, Yoo J. Cho HJ, et al. J Proteome Res. 2012 Apr 6;11(4):2355-64. doi: 10.1021/pr2011186. Epub 2012 Mar 12. J Proteome Res. 2012. PMID: 22364609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,873 results

Search Page